- Home
- ELVN vs PSEC Comparison
ELVN vs PSEC Comparison
Compare ELVN & PSEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVN
- PSEC
- Stock Information
- Founded
- ELVN 2016
- PSEC 2004
- Country
- ELVN United States
- PSEC United States
- Employees
- ELVN N/A
- PSEC N/A
- Industry
- ELVN Biotechnology: Pharmaceutical Preparations
- PSEC Finance/Investors Services
- Sector
- ELVN Health Care
- PSEC Finance
- Exchange
- ELVN Nasdaq
- PSEC Nasdaq
- Market Cap
- ELVN 1.2B
- PSEC 1.4B
- IPO Year
- ELVN 2020
- PSEC 2004
- Fundamental
- Price
- ELVN $19.72
- PSEC $2.81
- Analyst Decision
- ELVN Strong Buy
- PSEC Sell
- Analyst Count
- ELVN 5
- PSEC 1
- Target Price
- ELVN $41.20
- PSEC $2.50
- AVG Volume (30 Days)
- ELVN 421.4K
- PSEC 3.6M
- Earning Date
- ELVN 08-13-2025
- PSEC 11-07-2025
- Dividend Yield
- ELVN N/A
- PSEC 19.29%
- EPS Growth
- ELVN N/A
- PSEC N/A
- EPS
- ELVN N/A
- PSEC N/A
- Revenue
- ELVN N/A
- PSEC $719,436,000.00
- Revenue This Year
- ELVN N/A
- PSEC N/A
- Revenue Next Year
- ELVN $25.00
- PSEC N/A
- P/E Ratio
- ELVN N/A
- PSEC N/A
- Revenue Growth
- ELVN N/A
- PSEC N/A
- 52 Week Low
- ELVN $13.30
- PSEC $2.73
- 52 Week High
- ELVN $30.03
- PSEC $5.57
- Technical
- Relative Strength Index (RSI)
- ELVN 47.40
- PSEC 37.72
- Support Level
- ELVN $18.80
- PSEC $2.83
- Resistance Level
- ELVN $21.30
- PSEC $2.92
- Average True Range (ATR)
- ELVN 0.99
- PSEC 0.07
- MACD
- ELVN -0.06
- PSEC 0.00
- Stochastic Oscillator
- ELVN 36.80
- PSEC 19.00
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About PSEC Prospect Capital Corporation
Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests mainly in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.